Prudential Financial
NUVB icon

Prudential Financial’s Nuvation Bio NUVB Stock Holding History

Prudential Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
41,310
+4,280
+12% +$20.9K ﹤0.01% 2179
2026
Q1 		$159K Buy
37,030
+22,740
+159% +$127K ﹤0.01% 2174
2025
Q4 		$128K Sell
14,290
-15,740
-52% -$97.5K ﹤0.01% 2106
2025
Q3 		$111K Buy
30,030
+1,125
+4% +$3.07K ﹤0.01% 2269
2025
Q2 		$56.4K Buy
28,905
+15,290
+112% +$31.8K ﹤0.01% 2335
2025
Q1 		$24K Buy
13,615
+1,400
+11% +$3.19K ﹤0.01% 2244
2024
Q4 		$32.5K Hold
12,215
– – ﹤0.01% 2248
2024
Q3 		$28K Hold
12,215
– – ﹤0.01% 2682
2024
Q2 		$35.7K Buy
+12,215
New +$37.3K ﹤0.01% 2646
2022
Q2 		– Sell
-10,105
Closed -$53K – 2729
2022
Q1 		$53K Hold
10,105
– – ﹤0.01% 2570
2021
Q4 		$86K Buy
+10,105
New +$92.9K ﹤0.01% 2583

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Prudential Financial's NUVB Position: Q2 2026 in Review

Prudential Financial increased its Nuvation Bio (NUVB) stake by 12% in Q2 2026, buying an estimated $20.9K and bringing the position to 41,310 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Prudential Financial first reported a position in NUVB in Q4 2021 and has held it in 11 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Prudential Financial held 41,310 shares of Nuvation Bio worth $235K as of Q2 2026.
  • Prudential Financial bought 4,280 Nuvation Bio shares in Q2 2026, an estimated $20.9K.
  • Nuvation Bio made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2179 holding.
  • Prudential Financial first reported a position in Nuvation Bio in Q4 2021 and has held it in 11 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.